P. Wahlqvist

发表

A Review of Self-Report Instruments Measuring Health-Related Work Productivity

M. Prasad, P. Wahlqvist, R. Shikiar, 2012, PharmacoEconomics.

Systematic review: the impact of gastro‐oesophageal reflux disease on work productivity

P. Wahlqvist, A. Barkun, M. C. Reilly, 2006, Alimentary pharmacology & therapeutics.

PMD19 A CRITICAL REVIEW OF HEALTH-RELATED PRODUCTIVITY MEASURES

M. Prasad, P. Wahlqvist, R. Shikiar, 2002 .

Cost Effectiveness of Esomeprazole Compared with Omeprazole in the Acute Treatment of Patients with Reflux Oesophagitis in the UK

P. Wahlqvist, O. Junghard, A. Higgins, 2012, PharmacoEconomics.

Cost Effectiveness of Proton Pump Inhibitors in Gastro-Oesophageal Reflux Disease Without Oesophagitis

P. Wahlqvist, O. Junghard, A. Higgins, 2012, PharmacoEconomics.

Pharmacoeconomic aspects of non-steroidal anti-inflammatory drug gastropathy.

P. Wahlqvist, A. Walan, 1999, Italian journal of gastroenterology and hepatology.

Management of gastroduodenal ulcers and gastrointestinal symptoms associated with nonsteroidal anti-inflammatory drug therapy : A summary of four comparative trials with omeprazole, ranitidine, misoprostol, and placebo

P. Wahlqvist, I. Wiklund, G. Långström, 2001 .

Six‐month management of patients following treatment for gastroesophageal reflux disease symptoms – a Norwegian randomized, prospective study comparing the costs and effectiveness of esomeprazole and ranitidine treatment strategies in a general medical practitioners setting

P. Wahlqvist, H. Fagertun, B. Moum, 2005, International journal of clinical practice.

Impact of functional dyspepsia on quality of life and health care consumption after cessation of antisecretory treatment. A multicentre 3-month follow-up study.

P. Wahlqvist, I. Wiklund, N. Talley, 1999, Scandinavian journal of gastroenterology.

Symptoms of gastroesophageal reflux disease, perceived productivity, and health-related quality of life.

P. Wahlqvist, 2001, The American journal of gastroenterology.

PGI1 COMORBIDITIES DURING THE YEAR FOLLOWING DIAGNOSIS FOR PERSONS WITH AND WITHOUT GERD USING THE AGENCY FOR HEALTH RESEARCH AND QUALITY (AHRQ) 261 SPECIFIC CATEGORIES

P. Wahlqvist, M. Wallander, N. Talley, 2007 .

PMH71 The Impact of Once-Daily Extended-Release Quetiapine Fumarate (Quetiapine XR) on Length and Costs of Hospitalisation of Patients with Schizophrenia or Bipolar Disorder

P. Wahlqvist, H. Eriksson, U. Gustafsson, 2011 .

PMH72 The Impact of Once-Daily Extended-Release Quetiapine Fumarate (Quetiapine XR) on Length of Hospitalisation of Patients with Acute Bipolar Mania

P. Wahlqvist, M. Bonafede, H. Eriksson, 2011 .

Validity of a Work Productivity and Activity Impairment questionnaire for patients with symptoms of gastro-esophageal reflux disease (WPAI-GERD)--results from a cross-sectional study.

P. Wahlqvist, I. Wiklund, J. Carlsson, 2002, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Employers Need to Have a Wider Horizon Than Drug Costs Alone When Considering the Implementation of Health Care Intervention Programs

P. Wahlqvist, 2006, Journal of managed care pharmacy : JMCP.

Relationship between symptom load of gastro‐oesophageal reflux disease and health‐related quality of life, work productivity, resource utilization and concomitant diseases: survey of a US cohort

P. Wahlqvist, M. Wallander, J. Carlsson, 2008, Alimentary pharmacology & therapeutics.

The impact of illness in patients with moderate to severe gastro-esophageal reflux disease

G. Guyatt, P. Wahlqvist, A. Barkun, 2005, BMC gastroenterology.

Randomised clinical trial: the burden of illness of uninvestigated dyspepsia before and after treatment with esomeprazole – results from the STARS II study

P. Wahlqvist, N. Talley, K. Lauritsen, 2011, Alimentary pharmacology & therapeutics.

Impact of once-daily extended-release quetiapine fumarate on hospitalization length in patients with acute bipolar mania.

P. Wahlqvist, M. Bonafede, H. Eriksson, 2015, Journal of comparative effectiveness research.

Management of nonsteroidal anti-inflammatory drug-associated lesions: a cost-effectiveness perspective.

P. Wahlqvist, B. Jönsson, B Jönsson, 1998, The American journal of medicine.

The Burden of Disrupting Gastro-Oesophageal Reflux Disease

P. Wahlqvist, S. Bolge, D. Johnson, 2010, Clinical drug investigation.

Cost and burden of gastroesophageal reflux disease among patients with persistent symptoms despite proton pump inhibitor therapy: an observational study in France

P. Wahlqvist, M. Ruth, S. Bruley des Varannes, 2013, BMC Gastroenterology.

The Work Productivity and Activity Impairment Questionnaire for Patients with Gastroesophageal Reflux Disease (WPAI-GERD)

G. Guyatt, P. Wahlqvist, A. Barkun, 2012, PharmacoEconomics.

Cost-effectiveness of Simple Insulin Infusion Devices Compared to Multiple Daily Injections in Uncontrolled Type 2 Diabetics in the United States Based on a Simulation Model

P. Wahlqvist, R. Morlock, J. Warner, 2018, Journal of health economics and outcomes research.

PGU7: IN FINLAND, SWEDEN AND THE UK, ESOMEPRAZOLE IS COST-EFFECTIVE COMPARED WITH OMEPRAZOLE FOR THE ACUTE TREATMENT OF PATIENTS WITH REFLUX OESOPHAGITIS

P. Wahlqvist, 2000 .

PGU12: IN FINLAND, SWEDEN AND THE UK, ON DEMAND TREATMENT WITH ESOMEPRAZOLE IS COST-EFFECTIVE IN PATIENTS WITH GORD WITHOUT OESOPHAGITIS

P. Wahlqvist, 2000 .

Partial response to proton pump inhibitor therapy for GERD: observational study of patient characteristics, burden of disease, and costs in the USA

P. Wahlqvist, B. Spiegel, M. Karlsson, 2012, Pragmatic and observational research.

Cost of gastro‐oesophageal reflux disease to the employer: a perspective from the United States

P. Wahlqvist, M. Wallander, N. Kleinman, 2007, Alimentary pharmacology & therapeutics.

Impact of extended-release quetiapine fumarate on hospitalization length and cost in schizophrenia and bipolar disorder patients: a retrospective, hospital-based, US-cohort analysis.

P. Wahlqvist, H. Eriksson, U. Gustafsson, 2014, Journal of comparative effectiveness research.

Objective Measurement of Work Absence and On-The-Job Productivity: A Case-Control Study of US Employees With and Without Gastroesophageal Reflux Disease

P. Wahlqvist, M. Wallander, N. Kleinman, 2008, Journal of occupational and environmental medicine.

Objective Measurement of Work Absence and On-The-Job Productivity: A Case-Control Study of US Employees With and Without Gastroesophageal Reflux Disease

P. Wahlqvist, M. Wallander, N. Kleinman, 2008, Journal of occupational and environmental medicine.